LEVAMISOLE REGULATES THE PROLIFERATION OF MURINE LIVER T-CELLS THROUGH KUPFFER-CELL-DERIVED CYTOKINES

We have previously shown that levamisole increases the cytotoxic, cyto static, and proliferative activity of murine nonparenchymal liver cell s (NPC) in vitro. We have also shown that the nonadherent subpopulatio n of NPC, which are composed predominantly of T lymphocytes, is very r esponsive to this agent when administered to mice. Kupffer cells or im migrant macrophages are also responsive to levamisole but to a lesser extent. These findings prompted us to investigate changes in cytokine production by NPC following-treatment of mice with levamisole (25 mg/k g, i.p.), which may help explain the observed alterations in the immun e functions of these cells. We found that levamisole treatment of mice causes a threefold increase in production of interferon (IFN) alpha/b eta by adherent NPC (more than 80%-90% Kupffer cells) in vitro. When I FN alpha/beta was added to cultured cells, it decreased the proliferat ive capacity of liver T cells in a dose-dependent manner. In contrast, the addition of anti-IFN alpha/beta was shown to augment levamisole-i nduced proliferation of unfractionated NPC and Kupffer cells. NPC prod uction of interleukin 1 (IL-1) and interleukin-6 (IL-6) in vitro was a lso increased threefold following treatment of mice with levamisole. I L-6 added in vitro to cells significantly augmented levamisole-induced proliferation of liver T cells while anti-IL-6 reduced proliferative activity to control levels. These findings suggested that IFN alpha/be ta, IL-6, and IL-1 play important regulatory roles in controlling the proliferative response of murine liver-associated T lymphocytes to lev amisole. Finally, the proliferation of bone marrow cells was increased in mice given 5-fluorouracil (5FU). On the other hand, the proliferat ion of NPC was dramatically suppressed when 5FU was administered. Howe ver, the proliferation of these cells was restored when levamisole was given after 5FU.